Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

81 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Neutralizing and binding anti-interferon-beta (IFN-beta) antibodies. A comparison between IFN-beta-1a and IFN-beta-1b treatment in multiple sclerosis.
Kivisäkk P, Alm GV, Fredrikson S, Link H. Kivisäkk P, et al. Eur J Neurol. 2000 Jan;7(1):27-34. doi: 10.1046/j.1468-1331.2000.00002.x. Eur J Neurol. 2000. PMID: 10809912 Clinical Trial.
Factors associated with recovery from acute optic neuritis in patients with multiple sclerosis.
Malik MT, Healy BC, Benson LA, Kivisakk P, Musallam A, Weiner HL, Chitnis T. Malik MT, et al. Among authors: kivisakk p. Neurology. 2014 Jun 17;82(24):2173-9. doi: 10.1212/WNL.0000000000000524. Epub 2014 May 21. Neurology. 2014. PMID: 24850491 Free PMC article.
Circulating microRNAs as biomarkers for disease staging in multiple sclerosis.
Gandhi R, Healy B, Gholipour T, Egorova S, Musallam A, Hussain MS, Nejad P, Patel B, Hei H, Khoury S, Quintana F, Kivisakk P, Chitnis T, Weiner HL. Gandhi R, et al. Among authors: kivisakk p. Ann Neurol. 2013 Jun;73(6):729-40. doi: 10.1002/ana.23880. Epub 2013 Jul 8. Ann Neurol. 2013. PMID: 23494648
A randomized controlled double-masked trial of albuterol add-on therapy in patients with multiple sclerosis.
Khoury SJ, Healy BC, Kivisäkk P, Viglietta V, Egorova S, Guttmann CR, Wedgwood JF, Hafler DA, Weiner HL, Buckle G, Cook S, Reddy S. Khoury SJ, et al. Among authors: kivisakk p. Arch Neurol. 2010 Sep;67(9):1055-61. doi: 10.1001/archneurol.2010.222. Arch Neurol. 2010. PMID: 20837847 Free PMC article. Clinical Trial.
Increased leptin and A-FABP levels in relapsing and progressive forms of MS.
Messina S, Vargas-Lowy D, Musallam A, Healy BC, Kivisakk P, Gandhi R, Bove R, Gholipour T, Khoury S, Weiner HL, Chitnis T. Messina S, et al. Among authors: kivisakk p. BMC Neurol. 2013 Nov 11;13:172. doi: 10.1186/1471-2377-13-172. BMC Neurol. 2013. PMID: 24215402 Free PMC article.
Reversible neural stem cell niche dysfunction in a model of multiple sclerosis.
Rasmussen S, Imitola J, Ayuso-Sacido A, Wang Y, Starossom SC, Kivisäkk P, Zhu B, Meyer M, Bronson RT, Garcia-Verdugo JM, Khoury SJ. Rasmussen S, et al. Among authors: kivisakk p. Ann Neurol. 2011 May;69(5):878-91. doi: 10.1002/ana.22299. Epub 2011 Mar 9. Ann Neurol. 2011. PMID: 21391234 Free PMC article.
Investigation of probiotics in multiple sclerosis.
Tankou SK, Regev K, Healy BC, Cox LM, Tjon E, Kivisakk P, Vanande IP, Cook S, Gandhi R, Glanz B, Stankiewicz J, Weiner HL. Tankou SK, et al. Among authors: kivisakk p. Mult Scler. 2018 Jan;24(1):58-63. doi: 10.1177/1352458517737390. Mult Scler. 2018. PMID: 29307299 Clinical Trial.
Regression analysis of metabolite concentrations estimated from localized proton MR spectra of active and chronic multiple sclerosis lesions.
Helms G, Stawiarz L, Kivisäkk P, Link H. Helms G, et al. Among authors: kivisakk p. Magn Reson Med. 2000 Jan;43(1):102-10. doi: 10.1002/(sici)1522-2594(200001)43:1<102::aid-mrm12>3.0.co;2-i. Magn Reson Med. 2000. PMID: 10642736 Clinical Trial.
Elevated CD40 ligand expressing blood T-cell levels in multiple sclerosis are reversed by interferon-beta treatment.
Teleshova N, Bao W, Kivisäkk P, Ozenci V, Mustafa M, Link H. Teleshova N, et al. Among authors: kivisakk p. Scand J Immunol. 2000 Mar;51(3):312-20. doi: 10.1046/j.1365-3083.2000.00688.x. Scand J Immunol. 2000. PMID: 10736102
Multiple sclerosis: a study of chemokine receptors and regulatory T cells in relation to MRI variables.
Putheti P, Morris M, Stawiarz L, Teleshova N, Kivisäkk P, Pashenkov M, Kouwenhoven M, Wiberg MK, Bronge L, Huang YM, Söderström M, Hillert J, Link H. Putheti P, et al. Among authors: kivisakk p. Eur J Neurol. 2003 Sep;10(5):529-35. doi: 10.1046/j.1468-1331.2003.00638.x. Eur J Neurol. 2003. PMID: 12940835
81 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback